Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Rank in Stocks #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Share Price
$0.04367217
Last synced: 2026-08-17
Market Cap
$10.06M
Change (1 day)
3.99%
Change (1 year)
-26.77%
Country
SE
Trade IDL Diagnostics AB (publ) (IDLDX)

Category

Stock price history for IDL Diagnostics AB (publ) (IDLDX)
Highest end of day price: $0.04 on 2026-08-01

Lowest end of day price: $0.66 on 2011-05-01
Stock price history of IDL Diagnostics AB (publ) from 2011 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 6.57%
2025 9.67%
2024 -12.09%
2023 -20.98%
2022 -57.24%
2021 -56.70%
2020 105.13%
2019 -47.78%
2018 -46.79%
2017 -31.41%
2016 -39.64%
2015 56.69%
2014 -37.92%
2013 65.83%
2012 40.59%
2011 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$586.41 20.28%
US
$202.37 -3.18%
US
$24.18 79.18%
CN
$314.26 95.01%
US
$544.68 -14.61%
US